M. Candelaria Hernández, “Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS)”, Grhta, vol. 4, no. 1, pp. 114–121, May 2017.